Press Release: European Medicines Agency recommends new advice to surgeons on safer use of fibrin sealants Evicel and Quixil

Author (Corporate)
Series Title
Series Details EMA/CHMP/734886/2012 (16.11.12)
Publication Date 16/11/2012
Content Type

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), in November 2012, recommended a number of risk-minimisation measures for the fibrin sealants, Evicel and Quixil, to minimise the risk of gas embolism when these medicines are applied as spray during surgery.
Source Link http://www.emea.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2012/11/news_detail_001659.jsp&mid=WC0b01ac058004d5c1
Related Links
EMA: Press Release: EMA/CHMP/734886/2012 (16.11.12) http://www.emea.europa.eu/docs/en_GB/document_library/Press_release/2012/11/WC500134851.pdf
Subject Categories
Countries / Regions